Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22235243 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin

Indicates status has not been verified in more than two years